ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.
May 09, 2024The first commercial manufacturing run of LYFGENIA – a one-time gene therapy for the treatment of sickle cell disease developed by bluebird bio – was performed at its Allendale, NJ site. -
Sickle Cell Plagues Many Black Americans, But There's Hope for Better Treatments
June 21, 2021It's been more than six months since Brandy Compton last landed in a hospital emergency room. -
GBT heads to FDA with sickle cell drug voxelotor
December 05, 2018Global Blood Therapeutics (GBT) has persuaded the FDA to accept biomarker data from a phase III trial of sickle cell disease drug voxelotor as part of a filing for accelerated approval..... -
Gene Therapy for Sickle Cell Takes Another Step Forward
December 05, 2018A new gene therapy shows early promise against sickle cell anemia, researchers say.The therapy targets the genetic flaw that causes sickle cell....... -
Sickle Cell Trait Tied to Higher Kidney Failure Risk for Blacks
March 10, 2017Black people with a trait for sickle cell anemia appear to have double the risk of kidney failure that requires dialysis, new research suggests.
Pharma Sources Insight January 2025
